Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion
NASDAQ:BNGO

Bionano Genomics (BNGO) Stock Price, News & Analysis

Bionano Genomics logo
$1.23 -0.01 (-0.81%)
Closing price 04:00 PM Eastern
Extended Trading
$1.23 0.00 (-0.41%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Bionano Genomics Stock (NASDAQ:BNGO)

Advanced

Key Stats

Today's Range
$1.23
$1.30
50-Day Range
$1.11
$1.46
52-Week Range
$1.06
$5.50
Volume
188,001 shs
Average Volume
155,549 shs
Market Capitalization
$14.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00
Consensus Rating
Hold

Company Overview

Bionano Genomics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
36th Percentile Overall Score

BNGO MarketRank™: 

Bionano Genomics scored higher than 36% of companies evaluated by MarketBeat, and ranked 693rd out of 858 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Bionano Genomics has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.

  • Upside Potential

    Bionano Genomics has a consensus price target of $6.00, representing about 387.8% upside from its current price of $1.23.

  • Amount of Analyst Coverage

    Bionano Genomics has only been the subject of 2 research reports in the past 90 days.

  • Read more about Bionano Genomics' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Bionano Genomics is -0.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Bionano Genomics is -0.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Bionano Genomics has a P/B Ratio of 0.38. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    10.22% of the float of Bionano Genomics has been sold short.
  • Short Interest Ratio / Days to Cover

    Bionano Genomics has a short interest ratio ("days to cover") of 9.78.
  • Change versus previous month

    Short interest in Bionano Genomics has recently decreased by 1.63%, indicating that investor sentiment is improving.
  • Dividend Yield

    Bionano Genomics does not currently pay a dividend.

  • Dividend Growth

    Bionano Genomics does not have a long track record of dividend growth.

  • News Sentiment

    Bionano Genomics has a news sentiment score of 0.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.40 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Bionano Genomics this week, compared to 3 articles on an average week.
  • Search Interest

    Only 1 people have searched for BNGO on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added Bionano Genomics to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Bionano Genomics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.65% of the stock of Bionano Genomics is held by insiders.

  • Percentage Held by Institutions

    11.35% of the stock of Bionano Genomics is held by institutions.

  • Read more about Bionano Genomics' insider trading history.
Receive BNGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bionano Genomics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BNGO Stock News Headlines

Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company
We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel
See More Headlines

BNGO Stock Analysis - Frequently Asked Questions

Bionano Genomics' stock was trading at $1.53 at the start of the year. Since then, BNGO shares have decreased by 19.6% and is now trading at $1.23.

Bionano Genomics, Inc. (NASDAQ:BNGO) announced its quarterly earnings results on Wednesday, May, 13th. The company reported ($0.76) EPS for the quarter, beating the consensus estimate of ($0.88) by $0.12. The company earned $6.69 million during the quarter, compared to analysts' expectations of $6.57 million. Bionano Genomics had a negative net margin of 109.94% and a negative trailing twelve-month return on equity of 71.38%.
Read the conference call transcript
.

Shares of Bionano Genomics reverse split before market open on Monday, January 27th 2025.The 1-60 reverse split was announced on Wednesday, January 22nd 2025. The number of shares owned by shareholders was adjusted after the closing bell on Friday, January 24th 2025. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Bionano Genomics (BNGO) raised $30 million in an initial public offering (IPO) on Friday, September 21st 2018. The company issued 5,500,000 shares at a price of $5.00-$6.00 per share.

Top institutional shareholders of Bionano Genomics include Renaissance Technologies LLC (0.44%).
View institutional ownership trends
.

Shares of BNGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bionano Genomics investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), Waste Connections (WCN), AUO (AUOTY), American Water Works (AWK) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
5/13/2026
Today
5/21/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Measuring And Control Equipment
Current Symbol
NASDAQ:BNGO
CIK
1411690
Fax
N/A
Employees
300
Year Founded
2002

Price Target and Rating

High Price Target
$6.00
Low Price Target
$6.00
Potential Upside/Downside
+387.8%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($4.37)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$26.40 million
Net Margins
-109.94%
Pretax Margin
-109.70%
Return on Equity
-71.38%
Return on Assets
-43.07%

Debt

Debt-to-Equity Ratio
0.09
Current Ratio
1.84
Quick Ratio
1.59

Sales & Book Value

Annual Sales
$28.51 million
Price / Sales
0.50
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.26 per share
Price / Book
0.38

Miscellaneous

Outstanding Shares
11,480,000
Free Float
11,400,000
Market Cap
$14.12 million
Optionable
No Data
Beta
1.62

Social Links

Don't wait for the SpaceX IPO Cover

The space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (NASDAQ:BNGO) was last updated on 5/21/2026 by MarketBeat.com Staff.
From Our Partners